1. Home
  2. NXL vs LIDR Comparison

NXL vs LIDR Comparison

Compare NXL & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • LIDR
  • Stock Information
  • Founded
  • NXL 2010
  • LIDR 2013
  • Country
  • NXL United States
  • LIDR United States
  • Employees
  • NXL N/A
  • LIDR N/A
  • Industry
  • NXL Medical Specialities
  • LIDR Auto Parts:O.E.M.
  • Sector
  • NXL Health Care
  • LIDR Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • NXL 10.0M
  • LIDR 10.2M
  • IPO Year
  • NXL 2022
  • LIDR N/A
  • Fundamental
  • Price
  • NXL $4.13
  • LIDR $1.05
  • Analyst Decision
  • NXL Strong Buy
  • LIDR Hold
  • Analyst Count
  • NXL 1
  • LIDR 1
  • Target Price
  • NXL $3.00
  • LIDR N/A
  • AVG Volume (30 Days)
  • NXL 4.3M
  • LIDR 117.8K
  • Earning Date
  • NXL 11-08-2024
  • LIDR 11-12-2024
  • Dividend Yield
  • NXL N/A
  • LIDR N/A
  • EPS Growth
  • NXL N/A
  • LIDR N/A
  • EPS
  • NXL N/A
  • LIDR N/A
  • Revenue
  • NXL $162,078.00
  • LIDR $225,000.00
  • Revenue This Year
  • NXL $51.39
  • LIDR N/A
  • Revenue Next Year
  • NXL $177.11
  • LIDR $2,650.00
  • P/E Ratio
  • NXL N/A
  • LIDR N/A
  • Revenue Growth
  • NXL 26.00
  • LIDR N/A
  • 52 Week Low
  • NXL $0.25
  • LIDR $0.92
  • 52 Week High
  • NXL $4.36
  • LIDR $5.37
  • Technical
  • Relative Strength Index (RSI)
  • NXL 68.88
  • LIDR 41.73
  • Support Level
  • NXL $2.40
  • LIDR $0.96
  • Resistance Level
  • NXL $4.36
  • LIDR $1.25
  • Average True Range (ATR)
  • NXL 0.63
  • LIDR 0.09
  • MACD
  • NXL 0.08
  • LIDR -0.00
  • Stochastic Oscillator
  • NXL 79.19
  • LIDR 31.03

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: